课题基金 / 基金详情

INSULIN RECEPTOR POSITIVE AND AUTOANTIGEN REACTIVE T CELLS IN TYPE 1 DIABETES

INSULIN RECEPTOR POSITIVE AND AUTOANTIGEN REACTIVE T CELLS IN TYPE 1 DIABETES
1 型糖尿病中胰岛素受体阳性和自身抗原反应性 T 细胞
批准号:
7606987
负责人:
TIHAMER ORBAN
金额:
$0.35万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2008-03-31

项目摘要

项目成果

TIHAMER ORBAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to analyze the characteristics of peripheral blood immune cells and measure humoral immune responses in Type 1 diabetes patients, relatives at high risk and relatives at low risk for developing Type 1 Diabetes, patients with other autoimmune diseases and normal, healthy control individuals. The study subjects' genetic analysis will include HLA typing. Specifically, but not exclusively, we will look at the role of insulin receptor positive and antigen reactive cells in the peripheral blood, with special emphasis on regulatory and other specialized cell populations,serum autoantibodies and disease predisposition. The study has the potential to find a cellular marker for human Type 1 diabetes mellitus and also to give us a better understanding of the disease process itself. The ability to monitor the activity of autoimmunity could help any future interventional tools too.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
THE TRIALNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES
CLINICAL TRIAL: NEW ONSET OF TYPE 1 DIABETES MMF/DZB CLINICAL TRIAL
CLINICAL TRIAL: NUTRITIONAL INTERVENTION TO PREVENT TYPE 1 DIABETES PILOT TRIAL
AUTOANTIGEN VACCINATION IN INDIVIDUALS WITH NEW ONSET TYPE 1 DIABETES MELLITUS
海外基金